BioNexus Gene Lab Corporation (BGLC) was incorporated in the State of Wyoming on May 12, 2017. On June 1, 2017, we acquired all of the outstanding capital stock of BGS Lab Sdn. Bdh., a Malaysian corporation (“Subsidiary”). The Subsidiary was incorporated in Malaysia on April 7, 2015. Our corporate structure is depicted below:
BioNexus Gene Lab Corp.
BioNexus Gene Lab Sdn. Bhd
Professor Liew and his team pioneered the early detection techniques on many diseases and disorders through his extensive research and clinical trials. He profiled the changes in blood gene expressions through cell-cell interactions during blood circulation throughout the body and subtle changes occurred in cells over time due to injury or disease, which could then be used to develop disease-specific molecular diagnostic assays.
Professor Liew began his research in 1968 and published more than 300 research papers and clinical trials in medical and peer review journals like Nature, JBC, Proc NAS, Circulation etc. His publications included the followings:
Mining the Dynamic Genome; A Method for Identifying Multiple Disease Signature Using Quantitative RNA Expression Analysis of a Single Blood Sample (Dec 2015)
The Peripheral Blood Transcriptome: New Insights into Disease and Risk Assessment. Mohr, S Liew CC. Trends in Molecular Medicine (October 2007).
Cardiovascular genetics and genomics for the cardiologist / edited by Liew CC and Victor J. Dzau (2007)
Molecular genetics and genomics of heart failure (Nat Rev Genet, Nov 2004)
Role of the adenomatous polyposis coli gene product in human cardiac development and disease (J Biol Chem
, Jun 2000)
A Genome-Based Resource for Molecular Cardiovascular Medicine (Circulation, 16 Dec 1997)
A catalogue of genes in the cardiovascular system as identified by expressed sequence tags (Proc Natl Acad Sci USA , Oct 1994)